2013 American Transplant Congress
Behavior of ADAMTS13 and Von Willebrand Factor Levels in Patients after Living Donor Liver Transplantation
Introduction : Thrombotic microangiopathy (TMA) is one of the important complications occurring after liver transplantation (LT), and it is suggested that a Von Willebrand factor…2013 American Transplant Congress
Impact of Donor-Specific Anti-HLA and Anti-Angiotensin-II Type 1 Receptor Antibodies on Graft Fibrosis after Immunosuppression Withdrawal in Pediatric Liver Transplantation
Pediatric living-donor liver transplant (LDLT) recipients can often exhibit a reduction or cessation of immunosuppression (IS); over the long term, a high incidence of progressive…2013 American Transplant Congress
Combination of Anti-BTLA Antibody (6B2) and Anti-PD-1 Antibody (PIM-2) Induced Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allograft
Background: Programmed death (PD)-1 has been implicated in peripheral tolerance, and the coinhibitory receptor B and T lymphocyte attenuator (BTLA) has been implicated in the…2013 American Transplant Congress
What Is the Best Treatment for BK Viremia after Kidney Transplantation: Results of a 5-Year Screening Study
Purpose: Various anecdotal reports have described clinical activity of cidofovir, leflunomide, and ciprofloxacin in clearing the BK virus. Our aim was to define the factors…2013 American Transplant Congress
Agonistic Anti-BTLA mAb (3C10) Induced Prolongation of Murine Cardiac Allograft and Generation of IL-10 Dependent Regulatory CD4+ T Cells, An
Background: The co-inhibitory receptor B and T lymphocyte attenuator (BTLA) has been implicated in the regulation of autoimmunity and may potentially play an important role…2013 American Transplant Congress
Clinical Outcomes in Sensitized Heart Transplant Patients Bridged with Left Ventricular Assist Devices
Center for Heart Transplant and Assist Device, Advocate Christ Medical Center, Oak Lawn, IL
Background: Patients with pre-transplant left ventricular assist devices (LVAD) develop circulating antibodies with potential donor reactivity after cardiac transplantion. The aim of this study was…2013 American Transplant Congress
Effect of Donor Right Hepatectomy on Regeneration of the Liver and the Spleen
Surgery, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea
Purpose: Donor hepatectomy for living donor liver transplantation accompanies physiomorphological changes of the liver and the spleen. Therefore, the long-term consequences of these organs should…2013 American Transplant Congress
Prospective Surveillance of Kidney Transplant Recipients for BK Viremia Can Reduce or Eliminate BK Virus Associated Nephropathy (BKVAN) Related Graft Loss: Results of a 5-Year Screening Study
Purpose: We aimed to identify the incidence and risk factors for BKVAN as well as measure the impact of immediate therapy on the graft and…2013 American Transplant Congress
Effect of Sirtuin 1 Gene Expression on Mouse Islet Graft Survival, The
Purpose: Islet transplantation is a promising therapy for Type 1 diabetes, however clinical application has not been as successful as organ transplantation due to early…2013 American Transplant Congress
Efficacy and Safety of Corticosteroid Withdrawal (CSW) in Kidney Transplant Recipients during Routine Practice: A Prospective, 4-Year Analysis from the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Prospective, long-term data on efficacy and safety outcomes following CSW versus corticosteroid continuation (CSC) in kidney transplant patients during routine clinical practice are largely unavailable.Methods:…
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 178
- Next Page »